5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.38%
Revenue growth above 1.5x HUH1V.HE's 1.08%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
138.16%
Gross profit growth above 1.5x HUH1V.HE's 0.48%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
17.40%
EBIT growth 1.25-1.5x HUH1V.HE's 13.94%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
17.40%
Operating income growth 1.25-1.5x HUH1V.HE's 13.94%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
38.46%
Net income growth above 1.5x HUH1V.HE's 2.07%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
50.60%
EPS growth above 1.5x HUH1V.HE's 2.38%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
50.60%
Diluted EPS growth above 1.5x HUH1V.HE's 2.38%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-8.06%
Share reduction while HUH1V.HE is at 0.05%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-8.06%
Reduced diluted shares while HUH1V.HE is at 0.05%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-53.03%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-82.66%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-30.86%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 41.12%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-27.50%
Negative 5Y CAGR while HUH1V.HE stands at 31.32%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-5.39%
Negative 3Y CAGR while HUH1V.HE stands at 30.57%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
454.41%
Positive long-term OCF/share growth while HUH1V.HE is negative. John Neff would see a structural advantage in sustained cash generation.
-18.73%
Negative 5Y OCF/share CAGR while HUH1V.HE is at 1327.88%. Joel Greenblatt would question the firm’s operational model or cost structure.
243.74%
3Y OCF/share CAGR similar to HUH1V.HE's 256.85%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
128.82%
Net income/share CAGR 1.25-1.5x HUH1V.HE's 104.43%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
302.67%
5Y net income/share CAGR above 1.5x HUH1V.HE's 65.56%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
47.12%
3Y net income/share CAGR 75-90% of HUH1V.HE's 59.56%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
No Data
No Data available this quarter, please select a different quarter.
26.22%
5Y equity/share CAGR at 50-75% of HUH1V.HE's 42.69%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
27.90%
3Y equity/share CAGR at 50-75% of HUH1V.HE's 45.13%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.34%
AR growth well above HUH1V.HE's 7.54%. Michael Burry fears inflated revenue or higher default risk in the near future.
8.60%
Inventory growth well above HUH1V.HE's 9.54%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.29%
Asset growth well under 50% of HUH1V.HE's 2.49%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
6.68%
BV/share growth above 1.5x HUH1V.HE's 3.31%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
5.88%
We have some new debt while HUH1V.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Our R&D shrinks while HUH1V.HE invests at 32.43%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-5.58%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.